Jackson Creek Investment Advisors LLC Purchases New Holdings in Envista Holdings Corporation $NVST

Jackson Creek Investment Advisors LLC purchased a new stake in Envista Holdings Corporation (NYSE:NVST) in the 4th quarter, HoldingsChannel reports. The fund purchased 66,630 shares of the company’s stock, valued at approximately $1,447,000.

Other hedge funds and other institutional investors also recently added to or reduced their stakes in the company. Caitong International Asset Management Co. Ltd lifted its position in Envista by 16,711.1% in the 3rd quarter. Caitong International Asset Management Co. Ltd now owns 1,513 shares of the company’s stock worth $31,000 after buying an additional 1,504 shares in the last quarter. Allworth Financial LP lifted its position in Envista by 75.4% in the 4th quarter. Allworth Financial LP now owns 1,805 shares of the company’s stock worth $39,000 after buying an additional 776 shares in the last quarter. IFP Advisors Inc lifted its position in Envista by 102.9% in the 4th quarter. IFP Advisors Inc now owns 2,112 shares of the company’s stock worth $46,000 after buying an additional 1,071 shares in the last quarter. MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. lifted its position in Envista by 73.1% in the 2nd quarter. MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. now owns 2,248 shares of the company’s stock worth $44,000 after buying an additional 949 shares in the last quarter. Finally, EverSource Wealth Advisors LLC lifted its position in Envista by 378.0% in the 2nd quarter. EverSource Wealth Advisors LLC now owns 2,414 shares of the company’s stock worth $47,000 after buying an additional 1,909 shares in the last quarter.

Analyst Ratings Changes

A number of equities research analysts have issued reports on the stock. Weiss Ratings downgraded shares of Envista from a “hold (c)” rating to a “hold (c-)” rating in a research report on Monday, May 11th. Piper Sandler reiterated a “neutral” rating and issued a $25.00 target price (up from $21.00) on shares of Envista in a research report on Friday, February 6th. Leerink Partners set a $35.00 target price on shares of Envista and gave the stock an “outperform” rating in a research report on Friday, February 6th. Morgan Stanley increased their target price on shares of Envista from $19.00 to $21.00 and gave the stock an “equal weight” rating in a research report on Friday, April 24th. Finally, Mizuho increased their target price on shares of Envista from $24.00 to $27.00 and gave the stock a “neutral” rating in a research report on Tuesday, February 10th. Six equities research analysts have rated the stock with a Buy rating and nine have assigned a Hold rating to the company. According to data from MarketBeat, Envista has a consensus rating of “Hold” and a consensus price target of $28.83.

Envista Stock Performance

Shares of NVST opened at $23.32 on Thursday. The company’s fifty day moving average is $25.47 and its 200-day moving average is $24.41. Envista Holdings Corporation has a 12 month low of $17.78 and a 12 month high of $30.42. The firm has a market cap of $3.80 billion, a price-to-earnings ratio of 56.89, a price-to-earnings-growth ratio of 1.47 and a beta of 0.92. The company has a quick ratio of 2.06, a current ratio of 2.44 and a debt-to-equity ratio of 0.47.

Envista (NYSE:NVST) last announced its quarterly earnings results on Wednesday, May 6th. The company reported $0.36 EPS for the quarter, topping the consensus estimate of $0.31 by $0.05. Envista had a net margin of 2.41% and a return on equity of 7.11%. During the same quarter last year, the business posted $0.24 EPS. The company’s revenue for the quarter was up 14.4% on a year-over-year basis. Envista has set its FY 2026 guidance at 1.350-1.450 EPS. Equities analysts expect that Envista Holdings Corporation will post 1.43 EPS for the current fiscal year.

About Envista

Envista Holdings Corporation is a global dental products company that develops, manufactures and markets a broad portfolio of dental consumables, equipment and technology solutions. Headquartered in Brea, California, Envista serves dental practitioners, specialists and laboratories in more than 150 countries. The company’s offerings span implant, orthodontic, endodontic and restorative product lines as well as digital imaging systems and practice management software.

Envista’s product brands include Nobel Biocare for dental implants and restorative solutions, Ormco for orthodontic appliances and treatment systems, Kerr for restorative and endodontic materials, KaVo for dental imaging and handpieces, and Vista for surgical drills and instruments.